- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04981483
Conservative Surgery for Placenta Accreta
December 26, 2023 updated by: mohammed mahmoud samy, Ain Shams University
Long-term Follow-up of the Cases Who Underwent Conservative Surgery for Placenta Previa Accreta
A stepwise surgical approach for conservative management of placenta previa accreta.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
a stepwise surgical approach for conservative management of placenta previa accreta to preserve women's uterus and to evaluate the efficacy and safety of this approach in controlling postpartum hemorrhage including intrapartum hemorrhage associated with conservative management.
Study Type
Interventional
Enrollment (Actual)
62
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Abbaseya
-
Cairo, Abbaseya, Egypt
- Ain Shams Maternity Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Any age.
- Any parity.
- Previous one or more cesarean delivery.
- Placenta previa accreta diagnosis confirmed by gray scale & color flow Doppler ultrasound in 3rd trimester. All participants had undergone abdominal ultrasound showing placenta previa anterior completely covering the internal os, with criteria suggestive of invasion by U/S
Exclusion Criteria:
- women with medical disorder
- women with bleeding tendency
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Any age and parity with placenta accreta spectrum
After removal of the placenta, grasping the cervix from the both lips and one from each side of the cervical canal at the level of the internal os, each uterine angle and grasped the remaining lower uterine segment and Nelaton catheter was inserted inside the cervical canal to avoid closing the cervix with sutures of the uterine incision.Closing the uterine incision;taking suture at the lateral angle of the cervix and suturing it to the lower edge of the uterine angle, then another continuous suture was attached to the upper edge of the uterine incision angle[outside in-in out then out in-in out] and the same technique was repeated on the other side (cervico-isthmic sutures).
controlling bleeding from the inner surface of the remaining lower uterine segment was done by 2-3 interrupted sutures between the lower uterine segment and the anterior cervical lip.
closing of the uterine incision in continuous non-locking manner
|
After removal of the placenta, grasping the cervix from the both lips and one from each side of the cervical canal at the level of the internal os, each uterine angle and grasped the remaining lower uterine segment and Nelaton catheter was inserted inside the cervical canal to avoid closing the cervix with sutures of the uterine incision.Closing the uterine incision;taking suture at the lateral angle of the cervix and suturing it to the lower edge of the uterine angle, then another continuous suture was attached to the upper edge of the uterine incision angle[outside in-in out then out in-in out] and the same technique was repeated on the other side (cervico-isthmic sutures).
controlling bleeding from the inner surface of the remaining lower uterine segment was done by 2-3 interrupted sutures between the lower uterine segment and the anterior cervical lip.
closing of the uterine incision in continuous non-locking manner
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
incidence rate of conserving woman's uterus
Time Frame: intraoperative
|
success rate of conservative surgery for placenta accreta
|
intraoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
number of units of packed red blood cells , Fresh Frozen Plasma transfused ,postoperative haemoglobin
Time Frame: till 48 hours postpartum
|
to assess blood loss
|
till 48 hours postpartum
|
|
incidence rate of cesarean hysterectomy needed
Time Frame: intraoperative and 48 hours postpartum
|
failure of conservation , increase in blood loss
|
intraoperative and 48 hours postpartum
|
|
incidence of puerperal sepsis
Time Frame: till 6 weeks postpartum
|
temperature chart every 6 hours in 1st 48 hours postpartum then follow up visits 2 weeks and 6 weeks postpartum
|
till 6 weeks postpartum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: mahmoud ghaleb, lecturer, Ainshams university faculty of medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2018
Primary Completion (Actual)
April 15, 2019
Study Completion (Actual)
June 30, 2019
Study Registration Dates
First Submitted
July 6, 2021
First Submitted That Met QC Criteria
July 27, 2021
First Posted (Actual)
July 29, 2021
Study Record Updates
Last Update Posted (Actual)
December 29, 2023
Last Update Submitted That Met QC Criteria
December 26, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11784
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Placenta Accreta
-
Adana City Training and Research HospitalCompletedPlacenta Accreta Spectrum | Placenta PreviaTurkey (Türkiye)
-
Assiut UniversityNot yet recruitingPlacenta Accreta Management
-
Başakşehir Çam & Sakura City HospitalCompletedPlacenta Accreta Spectrum | Placenta Accreta / PercretaTurkey
-
Kasr El Aini HospitalUnknownPlacenta Accreta in Placenta Previa Anterior
-
FANG HERecruitingPlacenta Accreta SpectrumChina
-
Cairo UniversityNot yet recruiting
-
Assiut UniversityNot yet recruitingPlacenta Accreta SpectrumEgypt
-
Gaziantep City HospitalNot yet recruiting
-
Ain Shams Maternity HospitalCompleted
-
Sohag UniversityNot yet recruitingPlacenta Accreta Spectrum | Placenta Accreta | Placenta Previa
Clinical Trials on conservative surgery for uterus in placenta accreta
-
University of UtahActive, not recruiting
-
Tunis UniversityUniversity Tunis El ManarCompletedPlacenta Accreta | Post Partum Hemorrhage | Blood Loss MassiveTunisia
-
Kasr El Aini HospitalRecruitingPregnancy | Apgar Score | Tourniquets | Placenta Accrete SpectrumEgypt
-
Kanuni Sultan Suleyman Training and Research HospitalCompleted
-
Cairo UniversityRecruitingPlacenta Accreta With Bladder InvasionEgypt
-
Cairo UniversityCompleted
-
Assiut UniversityCompleted
-
Assiut UniversityNot yet recruiting
-
Ain Shams UniversityNot yet recruiting